Meeting to be held by webcast as a result of public health measures in response to the COVID-19 pandemic
Due to attendance restrictions at the Company’s planned venue and restrictions on in-person gatherings due to the COVID-19 pandemic, the AGM will be held as a hybrid meeting, accessible to shareholders via webcast.
The live webcast can be accessed using the following link: https://event.on24.com/wcc/r/2249409/457DAA61AC1F49A0D76FF15E235F1D3D.
The webcast will remain available for 12 months thereafter. To ensure a timely connection to the live webcast it is recommended that users register at least 15 minutes prior to the scheduled start time.
Following the event, the archived webcast and BELLUS Health’s corporate presentation will also be available on the Company’s website at www.bellushealth.com.
During the webcast, shareholders will be able to submit questions via the Q&A text box below the presentation.
Chronic cough, the lead indication for BLU-5937, is a cough lasting more than eight weeks and is associated with significant adverse physical, social and psychosocial effects on health and quality of life. It is estimated that approximately 26 million adults in
Chronic pruritus, commonly known as chronic itch, is an irritating sensation that leads to scratching, and persists for longer than six weeks, which can be debilitating and has a significant impact on quality-of-life. It is a hallmark of many conditions, including atopic dermatitis (“AD”). It is estimated that chronic pruritus associated with AD affects more than 16.9 million adults in
Director, Investor Relations and Communications